CD19 and multiple sclerosis: Recent studies have also shown that CD19 CAR T cells targeting B cell antigen CD19 have a good effect on crescentic glomerulonephritis (75), multiple sclerosis (76), systemic lupus erythematosus (77), and autoimmune rheumatic diseases (78).